Table 1.
Rat ID | Genotype | Sex | Age (weeks) | Tumor diagnose | IHC⁎ | LOH | Metastases |
---|---|---|---|---|---|---|---|
60 | −/− | Male | 18 | Hemangiosarcoma | Factor VIIIra+++ | — | Lung |
B-cell lymphoma | CD3+; CD79a+++ | — | Liver | ||||
61 | −/− | Male | 18 | Hemangiosarcoma† | Factor VIIIra+++ | — | Lung |
62 | −/− | Male | 18 | Hemangiosarcoma† | Factor VIIIra++ | — | Lung |
66 | −/− | Male | 20 | Adrenocortical carcinoma | NSE+; Factor VIIIra-; Synaptophysin-; Chromogranin A- | — | Lung |
76 | −/− | Male | 26 | Hemangiosarcoma† | ND | — | Lung |
77 | −/− | Male | 17 | ND‡ | — | — | |
140 | −/− | Female | 22 | No tumor detected | — | — | — |
164 | −/− | Male | 13 | Hemangiosarcoma | Factor VIIIra+++; Pankeratin-; Vimentin+++ | — | — |
198 | −/− | Male | 13 | Rhabdomyosarcoma; undifferentiated sarcoma | ND | — | — |
199 | −/− | Male | 14 | Hemangiosarcoma | ND | — | — |
223 | −/− | Female | 15 | Hemangiosarcoma | ND | — | Lung |
9 | +/− | Female | 36 | Rhabdomyosarcoma | MyoD1++; Factor VIIIra+ | Yes | Lung |
20 | +/− | Female | 45 | Osteosarcoma | ND | Yes | ND |
63 | +/− | Male | 50 | Sarcoma; transitional cell carcinoma in situ | ND | Yes | — |
74 | +/− | Male | 45 | No tumor detected | — | — | — |
75 | +/− | Male | 40 | ND‡ | — | ND | — |
82 | +/− | Male | 45 | Osteosarcoma | ND | Yes | Lung |
97 | +/− | Male | 47 | Osteosarcoma | ND | Yes | Lung |
100 | +/− | Female | 45 | Osteosarcoma | ND | Yes | — |
126 | +/− | Female | 31 | No tumor detected | — | — | — |
ND, not determined; LOH, loss of heterozygosity.
Immunohistochemistry used to determine tumor type. +++ indicates frequent expression of indicated marker, ++ indicates moderate expression, + means rare marker expression, and — means no marker expression found.
Primary tumor could not be identified; however multiple pulmonary metastases were found and used for IHC analyses.
Animal was found dead in the cage and in a decomposing state.